329 related articles for article (PubMed ID: 26231345)
1. Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements.
Ramos-Casals M; Brito-Zerón P; Seror R; Bootsma H; Bowman SJ; Dörner T; Gottenberg JE; Mariette X; Theander E; Bombardieri S; De Vita S; Mandl T; Ng WF; Kruize A; Tzioufas A; Vitali C;
Rheumatology (Oxford); 2015 Dec; 54(12):2230-8. PubMed ID: 26231345
[TBL] [Abstract][Full Text] [Related]
2. EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome.
Seror R; Ravaud P; Bowman SJ; Baron G; Tzioufas A; Theander E; Gottenberg JE; Bootsma H; Mariette X; Vitali C;
Ann Rheum Dis; 2010 Jun; 69(6):1103-9. PubMed ID: 19561361
[TBL] [Abstract][Full Text] [Related]
3. A single-center study of clinical features of pediatric Sjögren's syndrome.
Hou L; Wang N; Zhao C; Wang X; Du Y
Pediatr Rheumatol Online J; 2023 Oct; 21(1):119. PubMed ID: 37833819
[TBL] [Abstract][Full Text] [Related]
4. Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome?
Lendrem D; Mitchell S; McMeekin P; Gompels L; Hackett K; Bowman S; Price E; Pease CT; Emery P; Andrews J; Lanyon P; Hunter J; Gupta M; Bombardieri M; Sutcliffe N; Pitzalis C; McLaren J; Cooper A; Regan M; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Griffiths B; Ng WF;
Rheumatology (Oxford); 2015 Apr; 54(4):655-9. PubMed ID: 25240612
[TBL] [Abstract][Full Text] [Related]
5. Sjögren's disease activity associates with cardiovascular disease and monoclonal gammopathy: a university cohort study of disease activity and comorbidities.
Bohman BR; Dowds HS; Blagogee TE; Ike RW; Hansen KE; McCoy SS
Clin Rheumatol; 2024 Mar; 43(3):1093-1101. PubMed ID: 38326676
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Sjögren's syndrome in the general adult population in Spain: estimating the proportion of undiagnosed cases.
Narváez J; Sánchez-Fernández SÁ; Seoane-Mato D; Díaz-González F; Bustabad S
Sci Rep; 2020 Jun; 10(1):10627. PubMed ID: 32606345
[TBL] [Abstract][Full Text] [Related]
7. Beyond sicca: high prevalence and predictors of baseline and worsening systemic involvement in patients with Sjögren's disease.
Bandeira M; Silvério-António M; Khmelinskii N; Fonseca JE; Romão VC
Rheumatol Adv Pract; 2024; 8(2):rkae035. PubMed ID: 38560642
[TBL] [Abstract][Full Text] [Related]
8. National Sjögren's Foundation Survey: Burden of Oral and Systemic Involvement on Quality of Life.
McCoy SS; Bartels CM; Saldanha IJ; Bunya VY; Akpek EK; Makara MA; Baer AN
J Rheumatol; 2021 Jul; 48(7):1029-1036. PubMed ID: 32934136
[TBL] [Abstract][Full Text] [Related]
9. Impact of gender and age at onset on Sjögren's syndrome presentation and outcome: state of the art.
Fulvio G; La Rocca G; Chatzis LG; Ferro F; Navarro Garcia IC; Cafaro G; Goules AV; Bartoloni E; Baldini C
Clin Exp Rheumatol; 2023 Dec; 41(12):2547-2554. PubMed ID: 38149517
[TBL] [Abstract][Full Text] [Related]
10. A Case of Successful Immunosuppressive Therapy for Interstitial Lung Disease Associated with Sjögren's Syndrome With Double-positive Anti-SS-A and Anti-centromere Antibodies.
Suzuki K; Akiyama M; Kondo Y; Saito S; Kikuchi J; Hanaoka H; Kaneko Y
Intern Med; 2024 Mar; ():. PubMed ID: 38432977
[TBL] [Abstract][Full Text] [Related]
11. Treatment of non-systemic Sjögren's syndrome: Potential prevention of systematization with immunosuppressant agent/biotherapy.
Belbézier A; Nguyen TTT; Arnaud M; Ducotterd B; Vangout M; Deroux A; Mansard C; Sarrot-Reynauld F; Bouillet L
J Transl Autoimmun; 2024 Jun; 8():100238. PubMed ID: 38496268
[TBL] [Abstract][Full Text] [Related]
12. Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendations.
Brito-Zerón P; Theander E; Baldini C; Seror R; Retamozo S; Quartuccio L; Bootsma H; Bowman SJ; Dörner T; Gottenberg JE; Mariette X; Bombardieri S; de Vita S; Mandl T; Ng WF; Kruize AA; Tzioufas A; Vitali C; Buyon J; Izmirly P; Fox R; Ramos-Casals M;
Expert Rev Clin Immunol; 2016; 12(2):137-56. PubMed ID: 26691952
[TBL] [Abstract][Full Text] [Related]
13. Renal involvement in primary Sjögren syndrome.
François H; Mariette X
Nat Rev Nephrol; 2016 Feb; 12(2):82-93. PubMed ID: 26568188
[TBL] [Abstract][Full Text] [Related]
14. EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide.
Seror R; Bowman SJ; Brito-Zeron P; Theander E; Bootsma H; Tzioufas A; Gottenberg JE; Ramos-Casals M; Dörner T; Ravaud P; Vitali C; Mariette X; Asmussen K; Jacobsen S; Bartoloni E; Gerli R; Bijlsma JW; Kruize AA; Bombardieri S; Bookman A; Kallenberg C; Meiners P; Brun JG; Jonsson R; Caporali R; Carsons S; De Vita S; Del Papa N; Devauchelle V; Saraux A; Fauchais AL; Sibilia J; Hachulla E; Illei G; Isenberg D; Jones A; Manoussakis M; Mandl T; Jacobsson L; Demoulins F; Montecucco C; Ng WF; Nishiyama S; Omdal R; Parke A; Praprotnik S; Tomsic M; Price E; Scofield H; L Sivils K; Smolen J; Laqué RS; Steinfeld S; Sutcliffe N; Sumida T; Valesini G; Valim V; Vivino FB; Vollenweider C
RMD Open; 2015; 1(1):e000022. PubMed ID: 26509054
[TBL] [Abstract][Full Text] [Related]
15. Sjögren's syndrome-associated interstitial lung disease: A multicenter study.
Reina D; Roig Vilaseca D; Torrente-Segarra V; Cerdà D; Castellví I; Díaz Torné C; Moreno M; Narváez J; Ortiz V; Blavia R; Martín-Baranera M; Corominas H
Reumatol Clin; 2016; 12(4):201-5. PubMed ID: 26573882
[TBL] [Abstract][Full Text] [Related]
16. Rate, risk factors and causes of mortality in patients with Sjögren's syndrome: a systematic review and meta-analysis of cohort studies.
Singh AG; Singh S; Matteson EL
Rheumatology (Oxford); 2016 Mar; 55(3):450-60. PubMed ID: 26412810
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of belimumab given for 12 months in primary Sjögren's syndrome: the BELISS open-label phase II study.
De Vita S; Quartuccio L; Seror R; Salvin S; Ravaud P; Fabris M; Nocturne G; Gandolfo S; Isola M; Mariette X
Rheumatology (Oxford); 2015 Dec; 54(12):2249-56. PubMed ID: 26242856
[TBL] [Abstract][Full Text] [Related]
18. Sjögren syndrome: what and where are we looking for?
de Paiva CS; Rocha EM
Curr Opin Ophthalmol; 2015 Nov; 26(6):517-25. PubMed ID: 26367089
[TBL] [Abstract][Full Text] [Related]
19. One year in review 2016: Sjögren's syndrome.
Ferro F; Vagelli R; Bruni C; Cafaro G; Marcucci E; Bartoloni E; Baldini C
Clin Exp Rheumatol; 2016; 34(2):161-71. PubMed ID: 27095672
[TBL] [Abstract][Full Text] [Related]
20. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: A consensus and data-driven methodology involving three international patient cohorts.
Shiboski CH; Shiboski SC; Seror R; Criswell LA; Labetoulle M; Lietman TM; Rasmussen A; Scofield H; Vitali C; Bowman SJ; Mariette X;
Ann Rheum Dis; 2017 Jan; 76(1):9-16. PubMed ID: 27789466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
